AMRI Signs Development and Manufacturing Deal with Australian Firm
12:21 PM | April 17, 2012 | Deepti Ramesh
Albany Molecular Research Inc. (AMRI; Albany, NY) says it was selected by Biota (Melbourne Australia), a leading anti-infective drug development company, to further develop and manufacture the...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.